We only have this paper's title and publication details.
Read it at the sourcePolypharmacy is associated with clinically relevant sarcopenia, as assessed by a low ALM/BMI.
No takes yet. Share an insight, caveat, or question.
König et al. (2017) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: